Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
5.2
-20.83%
40%
—
30.58%
80%
—
5 Years
Score5.2
Net Growth-20.83%
Net Trend40%
Net Income Consistency—
Rev Growth30.58%
Rev Trend80%
Revenue Consistency—
Takeda Pharmaceutical Co Ltd ADR fundamental performance
Between 2021 and 2026, revenue grew from ¥ 3.19T to ¥ 4.77T and net income declined from ¥ 376.00B to ¥ 203.32B. Revenue increased in 4 of those 5 years; net income in 2.
Between 2016 and 2026, revenue grew from ¥ 1.80T to ¥ 4.77T and net income grew from ¥ 80.16B to ¥ 203.32B. Revenue increased in 8 of those 10 years; net income in 4.
Takeda Pharmaceutical Co Ltd ADR currently holds a 5-year HDB Score of 5.2 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 17.41 | — |
1 Year2025-08-12 | $ 14.07 | 23.70% |
5 Years2021-08-12 | $ 13.45 | 29.46% |
10 Years2016-08-12 | $ 14.87 | 17.07% |
All Time2008-10-27 | $ 9.58 | 81.68% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | 10 Years2016-08-12 | All Time2008-10-27 |
|---|---|---|---|---|---|
| Price | $ 17.41 | $ 14.07 | $ 13.45 | $ 14.87 | $ 9.58 |
| Return | — | 23.70% | 29.46% | 17.07% | 81.68% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2027 | ¥ 4.66T | ¥ 182.13B | ¥ 527.58B |
| 2026 | ¥ 4.77T | ¥ 203.32B | ¥ 597.63B |
| 2025 | ¥ 4.58T | ¥ 107.92B | ¥ 405.58B |
| 2024 | ¥ 4.26T | ¥ 144.06B | ¥ 472.88B |
| 2023 | ¥ 4.02T | ¥ 317.01B | ¥ 553.70B |
| 2022 | ¥ 3.56T | ¥ 230.05B | ¥ 875.00B |
| 2021 | ¥ 3.19T | ¥ 376.00B | ¥ 1.00T |
| 2020 | ¥ 3.29T | ¥ 44.24B | ¥ 653.43B |
| 2019 | ¥ 2.09T | ¥ 109.12B | ¥ 725.36B |
| 2018 | ¥ 1.77T | ¥ 186.88B | ¥ 375.16B |
| 2017 | ¥ 1.73T | ¥ 114.94B | ¥ 376.13B |
| 2016 | ¥ 1.80T | ¥ 80.16B | ¥ 560.02B |
| 2015 | ¥ 1.77T | -¥ 145.77B | ¥ 713.42B |
| 2014 | ¥ 1.69T | ¥ 106.65B | ¥ 851.02B |
| 2013 | ¥ 1.55T | ¥ 131.24B | ¥ 561.82B |
| 2012 | ¥ 1.50T | ¥ 124.16B | ¥ 460.52B |
| 2011 | ¥ 1.41T | ¥ 247.86B | ¥ 874.21B |
| 2010 | ¥ 1.46T | ¥ 297.74B | ¥ 883.21B |
| 2009 | ¥ 1.53T | ¥ 234.38B | ¥ 758.78B |
Explore beyond TAK
You're looking at Takeda Pharmaceutical Co Ltd ADR. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
